 SOUTH SAN FRANCISCO, Calif., May 20, 2021 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that Lawrence Blatt, Ph.D., MBA, CEO of Aligos, will present at the Jefferies Virtual Healthcare Conference being held June 1- 4, 2021. The presentation will be followed by a virtual QA session. 